ПЕРИТОНЕАЛЬНИЙ ДІАЛІЗ: ПРИЧИНИ НЕАДЕКВАТНОСТІ МЕТОДИКИ

  • A. I. Mogylnyk ВДНЗУ «Українська медична стоматологічна академія»
Ключові слова: перитонеальный диализ, физиология, перитонеальный транспорт, проницаемость мембраны, ультрафильтрация, несостоятельность методики.

Анотація

В последние годы всё большую распространенность в лечении больных хронической болезнью почек V стадии получает перитонеальный диализ. Возможность многолетнего использования этой методики почечной заместительной терапии остается ограниченной. В статье рассматриваются возможные причины несостоятельности методики перитонеального диализа в лечении пациентов с терминальной почечной недостаточностью.

Завантаження

Дані завантаження ще не доступні.

Посилання

39–year–old man with loss of ultrafiltration / J. W. Dobbie, R. T. Krediet, Z. J. Twardowski, W. K. Nichols // Perit. Dial. Int. – 1994. – Vol.14. – P. 384 – 394.

Adequacy of dialysis and nutrition in continuous ambulatory peritoneal dialysis: association with clinical outcomes / Canada – USA Peritoneal Dialysis Study Group // J. Am. Soc. Nephrol. – 1996. – Vol. 7. – P. 198 – 207.

Analysis of non enzymatic glycosylation in vivo: impact of different dialysis solutions / M. M. Ho–Dac– Pannekeet, M. F. Weiss, D. R. de Waart, P. Erhard [et al.] // Perit. Dial. Int. – 1999. – Vol. 19, suppl. 2 – P. 68 – 74.

Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis / M. M. Ho–dac–Pannekeet, B. Atasever, D. G. Struijk [et al.] // Perit. Dial. Int. – 1997. – Vol. 17, Issue 2. – P. 144 – 150.

Animal models for peritoneal dialysis / K. Wieczorowska–Tobis, A. Breborowicz, K. Pawlaczyk, M. Kuzlan–Pawlaczyk [et al.] // Perit. Dial. Int. – 1999. – Vol. 19, suppl. 2. – P. 189–192.

Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis? / C. E. Douma, D. R. de Waart, D. G. Struijk, R. T. Krediet / J. Lab. Clin. Med. – 1998. – Vol. 132. – P. 329 – 340.

Biocompatibility of a glucose–free, acidic lactated solution for peritoneal dialysis evaluated by population analysis of mesothelium / V. Wajsbrot, A. Shostak, L. Gotloib [et al.] // Nephron. – 1998. – Vol. 79. – P. 322 – 332.

Biocompatibility of peritoneal dialysis treatment / N. Paolo, G. Garosi, G. Monaci [et al.] // Nephrol. Dial. Transplant. – 1997. – Vol. 12, Issue 1. – P. 78 – 83.

Bistrup C. Technique survival and complication rates in a newly started CAPD centre (five years of experience) / C. Bistrup, А. Holm–Nielsen, R. S. Pedersen // Perit. Dial. Int. – 1996. – Vol. 16, Issue 1. – Р. 90 – 91.

Burkart J.M. Significance, epidemiology and prevention of peritoneal dialysis catheter infections / J.M. Burkart // Perit. Dial. Int. – 1996. – Vol. 16. – P. 340 – 346.

Carbonyl stress: increased carbonyl modification of tissue and cellular proteins in uremia / T. Miyata, Y. Izuhara, H. Sakai, K. Kurokawa // Perit. Dial. Int. – 1999. – Vol. 19, suppl. 2. – P. 58 – 61.

Conolly D. L. The aquaporins. A family of water channel proteins / D. L. Conolly, C. M. Shahan, P. L. Weissberg // Int. J. Biochem. Cell Biol. – 1998. - Vol. 30. – P. 169 – 172.

Daily exposure to dialysis fluid results in changes in peritoneal transport / T. Wang, A. R. Qureshi, O. Heimburger, J. Waniewski [et al.] // Perit. Dial. Int. – 1997.– Vol. 17. – P. 379 – 386.

Davies S. J. Monitoring of long–term peritoneal membrane function / S. J. Davies // Perit. Dial. Int. – 2000. – Vol. 21. – P. 225 – 230.

Demonstration of aquaporin–CHIP in peritoneal tissue of uremic and CAPD patients / M. M. Panekeet, J. B. Mulder, J. J. Weening, D. G. Struijk, M. M. Zweers, R. T. Krediet // Perit. Dial. Int. – 1996. – Vol. 16, suppl. l. – P. 54 – 57.

Dobbie J. W. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis / J. W. Dobbie // Perit. Dial. Int. – 1992. – Vol. 12. – P. 14 –

Expression of aquaporin–1 (AQP1) in a long–term peritoneal dialysis patient with impaired transcellular water transport / E. Goffin, S. Combet, F. Jama, J. Cosyns, O. Devuyst // Am. J. Kidney. Dis. – 1999. - Vol. 33. – P. 383 – 388.

FallerB. Evolution ofclinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years / B. Faller, N. Lameire // Nephrol. Dial. Transplant. – 1994. – Vol. 9. – P. 286 – 296.

Gotloib L. Population analysis of mesothelium in situ and in vivo exposed to bicarbonate–buffered peritoneal dialysis fluid / L. Gotloib, V.Wajsbrot, A. Shostak, // Nephron. – 1996. – V. 73. – P. 219 – 227.

Gotloib L. Acute and long–term changes observed in imprints of mouse mesothelium exposed to glucose– enriched, lactated, buffered dialysis solutions /

L. Gotloib, V.Wajsbrot, A. Shostak // Nephron. – Nephron 1995. – V. 70. – P. 466 – 477.

Ho–dac–Pannekeet M. M. Peritoneal transport characteristics with glucose polymer based dialysate / M. M. Ho–dac–Pannekeet, N. Schouten, M. J. Lan– gedijk [et al.] // Kidney. Int. – 1996. – Vol. 50. – P. 979 – 986.

Ho–dac–Pannekeet M. M. Water channels in the peritoneum / M. M. Ho–dac–Pannekeet, R. T. Krediet // Perit. Dial. Int. – 1996. – Vol. 16. – P. 255 – 259.

Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24–h dialysate creatinine clearance / N. Posthuma, P. M. ter Wee, H. A. Verbrugh [et al.] // Nephrol. Dial. Transplant. – 1997. – Vol. 12, Issue 3. – P. 550 – 553.

Icodextrin use is CCPD patients during peritonitis: ultrafiltration and serum disaccharide concentrations / N. Posthuma, P. M. Weel, A. J. M. Donnker, E. M. Peers, P. L. Oe, H. A. Vergrugh // Nephrol. Dial. Transplant. – 1998. – Vol. 13. – P. 2341 – 2344.

Impact of peritoneal membrane function on longterm clinical outcome in peritoneal dialysis patients / S. J. Davies, L. Phillips, A. M. Griffiths, L. H. Russel [et al.] // Perit. Dial. Int. – 1999. – Vol. 19, Issue 2. - P. 91 – 94.

Impact of surface area and permeability on solute clearances / R. T. Krediet, D. Zemel, A. L. T. Imholz, D. G. Struijk // Perit. Dial. Int. – 1994. – Vol. 14, suppl. 3. – P. 70 – 77.

In vitro testing a potentially biocompatible continuous ambulatory peritoneal dialysis fluid / N. Topley, R. K. Mackenzie, M. M. Peterson [et al.] // Nephrol. Dial. Transplant. –1999. – Vol. 6. – P. 574 – 581.

Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients / D. N. Churchill, K. E. Thorpe, K. D. Nolph [et al.] // J. Am. Soc. Nephrol. – 1998. – Vol. 9. – P. 1285 – 1292.

Increased peritoneal permeability is associated with decreased fluid and small solute removal and higher mortality in CAPD patients / T. Wang, O. Heimburger,

J. Waniewski, G. Bergstrom [et al.] // Nephrol. Dial. Transplant. – 1998. – Vol. 13. – P. 1279 – 1289.

Inhibition of nitric oxide synthase reverses changes in peritoneal permeability in a rat model of acute peritonitis / M. L. Ferrier, S. Combet, M. M. van Landschoot, M. S. Stoenoiu [et al.] // Kidney. Int. – 2001 – Vol. 60. – P. 2343 – 2350.

Issues affecting the longevity of the continuous peritoneal dialysis therapy / Y. Kawaguchi, T. Hasegawa, M. Nakayama, H. Kubo [et al.] // Kidney Int. – 1997. – Vol. 62. – P.105 – 107.

Jindal K. K. Excellent technique survival on home peritoneal dialysis: results of a regional program / K. K. Jindal, D. J. Hirsch // Perit. Dial. Int. – 1994. – Vol. 14. – P. 324 – 326.

Jorres A. Peritoneal dialysis: a biological membrane with a nonbiological fluid / A.Jorres, J. Witowski // Contrib. Nephrol. – 2009. – Vol. 163. – P. 27 – 34.

Jorres A. Peritoneal dialysis solution biocompatibility: inhibitory mechanisms and recent studies with bicarbonate–buffered solutions / A. Jorres, J. D. Williams, N. Topley // Perit. Dial. Int. – 1997. – Vol. 17, suppl. 2. – P. 42 – 46.

Krediet R. T. Pathophysiology of peritoneal membrane failure / R. T. Krediet, B. Lindholm, B. Rippe // Perit. Dial. Int. – 2000. – Vol. 20, Issue 4. – P. 2242.

Krediet R. T. Preservation of peritoneal membrane function / R. T. Krediet, M. M. Ho–Dac–Pannekeet, D. G. Struijk // Kidney. Int. – 1996. – Vol. 50, Issue 56.– P. 62 – 68.

Krediet R. T. Prevention and treatment of peritoneal dialysis membrane failure / Krediet R. T. // Adv. Renal. Repl. Ther. – 1998. – Vol. 5. – P. 211 – 213.

Longitudinal changes in peritoneal kinetics: the effect of peritoneal dialysis and peritonitis / S. J Davies, J. Bryan, L. Phillips [et al.] // Nephrol. Dial. Transplant. – 1996. – Vol. 11. – P. 506 – 556.

Longitudinal follow–up of CA 125 in peritoneal effluent / M. M. Ho–dac–Pannekeet, J. K. Hiralall, D. G. Struijk, R. T. Krediet // Kidney. Int. – 1997. – Vol. 51. – P. 888 – 893.

Mitic L. L. Molecular architecture of tight junctions / L. L. Mitic, J. M. Anderson // Annu. Rev. Physiol. – 1998. – Vol. 60. – P. 121 – 142.

Morphological and morphometric changes in mesothelial cells during peritoneal dialysis in the rabbit / N. Di. Paolo, G. Garosi, G. Petrini, G. Monaci // Nephron. – 1996. – Vol. 74. – P. 594 – 599.

Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure / K. Honda, K. Nitta, S. Horita, W. Yumura, H. Nihei // Nephron. – 1996. – Vol. 72. – P. 171 – 176.

Nitrate in stable CAPD patients and during peritonitis / C. E. Douma, D. R. de Waart, D. Zemel, A. L. Imholz, G. C. Koomen, D. G. Struijk [et al.] // Adv. Perit. Dial. – 1995. – Vol. 1. – P. 36 – 40.

Osmotic conductance of the peritoneum in CAPD patients with permanent loss of ultrafiltration capacity / J. Waniewski, O. Heimb rger, A. Werynski, B. Lindholm // Perit. Dial. Int. – 1996. – Vol.16. – P. 488 – 496.

ParkM. S. AGE accumulation in peritoneal membrane and cavity during peritoneal dialysis and its effect on peritoneal structure and function / M. S. Park,

H. B. Lee // Perit. Dial. Int. – 1999. – Vol. 19, Issue 2. – P. 53 – 57.

Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors and peritoneal transport kinetics / P.M.E.M. Hendriks,

M.M. Ho–dac–Pannekeet, T.M. van Gulik [et al.] // Perit. Dial. Int. – 1997. – Vol. 17. – P. 143 – 144.

Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity / O. Heimburger, J. Waniewski, A. Werynski [et al.] // Kidney Int. – 1990. – Vol. 38. – P. 495 – 506.

Rippe B. Clinical implications of a three–pore model of peritoneal transport / B.Rippe, O.Simonsen, G.Stelin // Peritoneal Dialysis Bulletin. – 1991. – Vol. 7. – P. 3 – 9.

Rippe B. Role of transcellular water channels in peritoneal dialysis / B. Rippe, O. Carlson // Perit. Dial. Int. – 1999. – Vol. 19, Issue 2. – P. 95 – 101.

ShostakA. Daily short exposure of cultured mesothelial cells to lactated, high–glucose, low pH peritoneal dialysis fluid induces a low–profile regenerative steady state / A. Shostak, K. Pivnik, L. Gotloib L. // Nephrol. Dial. Transplant. – 1996. – Vol. 11. – P. 608 – 613.

Stability of the peritoneal dialysis patients / R. Selgas, M. A. Bajo, A. Paiva [et al.] // Adv. Renal Repl. Ther. – 1998. – Vol. 5. – P. 168 – 178.

Superinduction of IL–6 synthesis in human peritoneal mesothelial cells is related to the induction and stabilization of IL–6 mRNA / J. Witowski, A. Jorres, G. A. Coles, J. D. Williams, N. Topley // Kidney. Int. – 1996. – Vol. 50. – P. 1212 – 1223.

The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients / M.M. Pannekeet, A.L.T. Imholz, D.G. Struijk [et al.] // Kidney Int. – 1995. – Vol. 48. – P. 866 – 875.

Topley N. In vitro biocompatibility of bicarbonate– based peritoneal dialysis solutions / N. Topley // Perit. Dial. Int. – 1997. – Vol. 17. – P. 42 – 47.

Waniewski J. Mathematical models for peritoneal transport characteristics / J. Waniewski // Perit. Dial. Int. – 1999. – Vol. 19, Issue 2. – P. 193 – 201.

Weiss M. F. Pathogenic role of advanced glycation end–products (AGEs): an overview / M. F. Weiss // Perit. Dial. Int. –1999. – Vol. 19, suppl. 2.– P. 47 – 52.

What realy happens to people on long–term peritoneal dialysis? / S. J. Davies, L. Phillips, A. M. Griffits,

L. H. Russell [et al.] // Kidney. Int. – 1998. – Vol. 54. – P. 2207 – 2217.

Wilkie M.E. Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: extension of CAPD technique survival / M. E.Wilkie, M.J. Plant, L. Edwards, C. B. Brown // Perit. Dial. Int. – 1997. – Vol. 17. – P. 84–87.

Wintour E. M. Water channels and urea transporters / E. M. Wintour // Clin. Exp. Pharmacol. Physiol. – 1997. – Vol.24. – P. 1 – 9.

Woodrow G. Technique failure in peritoneal dialysis and its impact on patient survival / G. Woodrow, J. H. Turney, M. Bownjohn // Perit. Dial. Int. – 1997. – Vol. 17. – P. 360 – 364.


Переглядів анотації: 384
Завантажень PDF: 296
Опубліковано
2014-01-27
Як цитувати
Mogylnyk, A. I. (2014). ПЕРИТОНЕАЛЬНИЙ ДІАЛІЗ: ПРИЧИНИ НЕАДЕКВАТНОСТІ МЕТОДИКИ. Український Журнал Нефрології та Діалізу, (1(41), 52-57. https://doi.org/10.31450/ukrjnd.1(41).2014.10